meRfi®-GM

CD73 (5′-Nucleotidase / Ecto-5′-Nucleotidase (NT5E))

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

CD73 as a potential opportunity for cancer immunotherapy
Ghalamfarsa et al. 2019
Review
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
Yang et al. 2020c
Ecto-enzyme and signaling functions of lymphocyte CD73
Resta et al. 1998 Immunol Rev 161: 95-109
Review
Potential of CD73 as a target for cancer immunotherapy
Jadidi-Niaragh 2019
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti- PD-1 therapy
Turiello et al. 2020